Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Proteomic Analysis of Inflammatory and Neurological Blood Biomarkers in Acute and Chronic COVID-19
EF 2025-26
Résumé
There have been almost 800 million recorded cases of COVID-19 worldwide. COVID-19 usually causes mild symptoms like fatigue and difficulty breathing, and brain-related symptoms like headaches, and loss of smell and taste. In severe cases, it can also cause life-threatening conditions like stroke. Most people recover from COVID-19 within weeks, but many continue to experience symptoms for longer, a condition known as long-COVID. One of the most common long-lasting symptoms of long-COVID is “brain fog”, which causes difficulties with memory and thinking, yet not much is understood about how COVID-19 affects the brain. Studies show that a few proteins found in the brain can also be measured in blood to predict stroke in patients with severe COVID-19. To expand on this research, we will use advanced technology to investigate more than 120 brain-related proteins in blood samples of short and long-term COVID-19 cases.
Measuring brain proteins in blood is a powerful research tool because they can reveal what is happening in the brain through a simple blood test instead of other complex tests such as brain imaging, spinal puncture, or subjective question-based tests. By looking at a larger set of proteins, we aim to identify patterns to group COVID-19 cases based on differences in protein levels. We will then determine connections between these groups and the different ways that the virus affects people, including the development of long-COVID. Our findings will bring us closer to developing clinical tools to detect and predict long-COVID and other COVID-19 complications, as well as their impacts on brain health. They will also improve our understanding of the virus, making us better prepared for possible resurgence of COVID-19 or appearance of similar viruses in the future.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572667
Name
Go Kristen Danielle
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Proteomic Analysis of Inflammatory and Neurological Blood Biomarkers in Acute and Chronic COVID-19
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Covid-19; Neurology; Nulisa; Plasma Biomarkers
Abstract
There have been almost 800 million recorded cases of COVID-19 worldwide. COVID-19 usually causes mild symptoms like fatigue and difficulty breathing, and brain-related symptoms like headaches, and loss of smell and taste. In severe cases, it can also cause life-threatening conditions like stroke. Most people recover from COVID-19 within weeks, but many continue to experience symptoms for longer, a condition known as long-COVID. One of the most common long-lasting symptoms of long-COVID is “brain fog”, which causes difficulties with memory and thinking, yet not much is understood about how COVID-19 affects the brain. Studies show that a few proteins found in the brain can also be measured in blood to predict stroke in patients with severe COVID-19. To expand on this research, we will use advanced technology to investigate more than 120 brain-related proteins in blood samples of short and long-term COVID-19 cases.
Measuring brain proteins in blood is a powerful research tool because they can reveal what is happening in the brain through a simple blood test instead of other complex tests such as brain imaging, spinal puncture, or subjective question-based tests. By looking at a larger set of proteins, we aim to identify patterns to group COVID-19 cases based on differences in protein levels. We will then determine connections between these groups and the different ways that the virus affects people, including the development of long-COVID. Our findings will bring us closer to developing clinical tools to detect and predict long-COVID and other COVID-19 complications, as well as their impacts on brain health. They will also improve our understanding of the virus, making us better prepared for possible resurgence of COVID-19 or appearance of similar viruses in the future.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Go, Kristen Danielle
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~